Cargando…
TTRAP Is a Novel Component of the Non-Canonical TRAF6-TAK1 TGF-β Signaling Pathway
Transforming growth factor-β (TGF-β) principally relays its effects through the Smad pathway however, accumulating evidence indicate that alternative signaling routes are also employed by this pleiotropic cytokine. For instance recently, we have demonstrated that ligand occupied TGF-β receptors can...
Autores principales: | Várady, György, Sarkadi, Balázs, Fátyol, Károly |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3182262/ https://www.ncbi.nlm.nih.gov/pubmed/21980489 http://dx.doi.org/10.1371/journal.pone.0025548 |
Ejemplares similares
-
Parkinson's Disease DJ-1 L166P Alters rRNA Biogenesis by Exclusion of TTRAP from the Nucleolus and Sequestration into Cytoplasmic Aggregates via TRAF6
por: Vilotti, Sandra, et al.
Publicado: (2012) -
Overexpression of TTRAP inhibits cell growth and induces apoptosis in osteosarcoma cells
por: Zhou, Caihong, et al.
Publicado: (2013) -
Role of the MAPKs/TGF-β1/TRAF6 signaling pathway in postoperative atrial fibrillation
por: Zhang, Daoliang, et al.
Publicado: (2017) -
Myricetin Alleviates Pathological Cardiac Hypertrophy via TRAF6/TAK1/MAPK and Nrf2 Signaling Pathway
por: Liao, Hai-han, et al.
Publicado: (2019) -
(+)-Vitisin A Inhibits Osteoclast Differentiation by Preventing TRAF6 Ubiquitination and TRAF6-TAK1 Formation to Suppress NFATc1 Activation
por: Chiou, Wen-Fei, et al.
Publicado: (2014)